Active	Status	Sponsor type	Region	Phase	Filter
3 Active 2 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Cellavita HD (stem-cell therapy for Huntington's Disease) / Cellavita Scientific Research
ADORE-EXT, NCT04219241: Clinical Extension Study for Safety and Efficacy Evaluation of Cellavita-HD Administration in Huntington's Patients.	Active, not recruiting	2/3	35	RoW	Cellavita-HD, cellular therapy, mesenchymal stem cells	Azidus Brasil, Cellavita Pesquisa Científica Ltda	Huntington Disease	12/22	12/22
SAVE-DH, NCT02728115: Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington's Disease	Active, not recruiting	1	6	RoW	Cellavita HD Lower Dose, cellular therapy, mesenchymal stem cells, Cellavita HD Higher dose	Azidus Brasil, Cellavita Pesquisa Científica Ltda, Azidus Brasil Scientific Research and Development Ltda	Huntington Disease	12/22	12/23
NestaCell (mesenchymal stem cells) / Cellavita Scientific Research
STAR, NCT06097780: Efficacy and Safety of NestaCell® in Huntington's Disease	Not yet recruiting	3	120	NA	NestaCell®	Azidus Brasil, Cellavita Pesquisa Científica Ltda	Huntington Disease	09/25	02/26